Reconstructed Human Small Intestine and Human Skin Models Microtissue Samples and Culture Media

The U.S. Food and Drug Administration’s Office of Acquisition and Grant Services is soliciting bids for reconstructed human small intestine and human skin models, along with associated microtissue samples and culture media, under solicitation number 75F40126Q132991. This is a total small business set-aside as defined under FAR 19.5, exclusively available to small businesses certified by the Small Business Administration, with the North American Industry Classification System code 325414 covering pharmaceutical and biological product manufacturing. All proposals must be submitted by 6:00 PM Eastern Time on July 17, 2026, and the contract will be awarded for performance at a location in Jefferson, Arkansas, with deliveries expected to meet strict biological and quality standards for research and regulatory applications. The primary point of contact for this solicitation is Howard Nesmith, reachable via email at howard.nesmith@fda.hhs.gov or by phone at 301-796-2138, and inquiries should be directed to him for clarification. The solicitation combines the synopsis and request for proposals into a single document, and interested parties must access the full details through the official SAM.gov portal. The contract is managed under the Department of Health and Human Services, with the issuing office headquartered in Rockville, Maryland. All submissions must comply with federal acquisition regulations and demonstrate the capability to consistently supply high-fidelity, biologically relevant human tissue models suitable for preclinical testing and scientific validation.